Uganda Launches Mpox Vaccination Campaign in Kampala
Kampala, February 2, 2025 – Uganda has initiated a targeted mpox vaccination campaign in the capital city, Kampala, which is the current epicenter of the viral outbreak in the East African nation.
Phase One Focuses on High-Risk Populations
Charles Olaro, director general of health services at the Ministry of Health, stated that the first phase of the vaccination effort is aimed at high-risk populations and healthcare workers. This strategy is designed to curb the human-to-human transmission of the highly contagious virus.
The vaccination program has commenced in areas marked by commercial sexual activity, transportation hubs, and informal markets in Kawempe and Makindye districts of Kampala. The initiative will subsequently extend to other remaining districts within the capital city and the central regions of Wakiso and Mukono.
Targeting Specific Groups
“Our primary focus is on high-risk populations, close contacts of confirmed cases, and healthcare workers in areas where active transmission is occurring,” explained Olaro.
Vaccine Supply and Usage
Africa Centers for Disease Control and Prevention has provided Uganda with approximately 2,000 doses of the mpox vaccine. These doses are sufficient to cover up to 1,000 individuals, according to health officials.
Outbreak Update
Since the outbreak was confirmed in August 2024, Uganda has reported 2,479 laboratory-confirmed mpox cases and 16 deaths as of January 28, 2025. A significant portion of the fatalities have underlying medical conditions such as HIV/AIDS, malnutrition, diabetes, and sickle cell disease.
International Concerns
In August 2024, the World Health Organization declared mpox a public health emergency of international concern, highlighting the potential for the virus to spread internationally.
Understanding Mpox
Mpox, or monkeypox, is a viral infection caused by the monkeypox virus. It is primarily transmitted through close contact and can manifest with symptoms such as fever, lymph node swelling, sore throat, muscle aches, skin rash, and back pain.
Conclusion
The targeted vaccination campaign in Uganda’s high-risk populations is a critical step in controlling the mpox outbreak. However, continued public health efforts and vigilance will be essential to prevent further spread.
We encourage our readers to stay informed about the latest developments and support initiatives aimed at eradicating this public health threat.
Join the conversation and share your thoughts. Leave a comment below or follow us on social media to stay updated on breaking news and health information.